Abstract
Annals of the New York Academy of SciencesVolume 780, Issue 1 p. 164-167 High and Low Behavioral Response to Novelty Is Associated with Differences in Neurotensin and Substance P Content PETER W. KALIVAS, Corresponding Author PETER W. KALIVAS aAlcohol and Drug Abuse Program Washington State University Pullman, Washingtonc Address for correspondence: Department of VCAPP, Washington State University, Pullman, WA 99164-6520.Search for more papers by this authorLLOYD BUSH, LLOYD BUSH bDepartment of Pharmacology and Toxicology University of Utah Salt Lake City, UtahSearch for more papers by this authorGLEN HANSON, GLEN HANSON bDepartment of Pharmacology and Toxicology University of Utah Salt Lake City, UtahSearch for more papers by this author PETER W. KALIVAS, Corresponding Author PETER W. KALIVAS aAlcohol and Drug Abuse Program Washington State University Pullman, Washingtonc Address for correspondence: Department of VCAPP, Washington State University, Pullman, WA 99164-6520.Search for more papers by this authorLLOYD BUSH, LLOYD BUSH bDepartment of Pharmacology and Toxicology University of Utah Salt Lake City, UtahSearch for more papers by this authorGLEN HANSON, GLEN HANSON bDepartment of Pharmacology and Toxicology University of Utah Salt Lake City, UtahSearch for more papers by this author First published: June 1996 https://doi.org/10.1111/j.1749-6632.1996.tb15120.xCitations: 2AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Citing Literature Volume780, Issue1Neuropeptides: Basic and Clinical AdvancesJune 1996Pages 164-167 RelatedInformation
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
